INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE

被引:504
作者
BAILEY, DG
SPENCE, JD
MUNOZ, C
ARNOLD, JMO
机构
[1] Department of Medicine, Victoria Hospital, University of Western Ontario, N6A4G5, 375 South Street, London, Ontario, Canada
关键词
D O I
10.1016/0140-6736(91)90872-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Six men with borderline hypertension took felodipine 5 mg with water, grapefruit juice, or orange juice. The mean felodipine bioavailability with grapefruit juice was 284 (range 164-469)% of that with water. The dehydrofelodipine/felodipine AUC ratio was lower, diastolic blood pressure lower, and heart rate higher with grapefruit juice than with water. Vasodilatation-related side-effects were more frequent. Orange juice had no such effects. Six healthy men took nifedipine 10 mg with water or grapefruit juice; the bioavailability with grapefruit juice was 134 (108-169)% of that with water.
引用
收藏
页码:268 / 269
页数:2
相关论文
共 10 条
[1]  
ANHOFF M, 1984, J PHARM BIOMED ANAL, V2, P519
[2]  
BAARNHIELM C, 1984, XENOBIOTICA, V14, P719
[3]  
BAILEY DG, 1989, CLIN INVEST MED, V12, P357
[4]  
BUENING MK, 1981, CANCER RES, V41, P67
[5]   CLINICAL PHARMACOKINETICS OF FELODIPINE - A SUMMARY [J].
EDGAR, B ;
LUNDBORG, P ;
REGARDH, CG .
DRUGS, 1987, 34 :16-27
[6]  
EDGAR B, 1990, CLIN PHARMACOL THER, V47, P181
[7]   ABSORPTION, DISTRIBUTION AND ELIMINATION OF FELODIPINE IN MAN [J].
EDGAR, B ;
HOFFMANN, KJ ;
LUNDBORG, P ;
REGARDH, CG ;
RONN, O ;
WEIDOLF, L .
DRUGS, 1985, 29 :9-15
[8]   FELODIPINE KINETICS IN HEALTHY-MEN [J].
EDGAR, B ;
REGARDH, CG ;
JOHNSSON, G ;
JOHANSSON, L ;
LUNDBORG, P ;
LOFBERG, I ;
RONN, O .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) :205-211
[9]   INVIVO OXIDATIVE CLEAVAGE OF A PYRIDINE-CARBOXYLIC ACID ESTER METABOLITE OF NIFEDIPINE [J].
FUNAKI, T ;
SOONS, PA ;
GUENGERICH, FP ;
BREIMER, DD .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (23) :4213-4216
[10]   EFFECT OF FOOD ON HEPATIC BLOOD-FLOW - IMPLICATIONS IN THE FOOD EFFECT PHENOMENON [J].
SVENSSON, CK ;
EDWARDS, DJ ;
MAURIELLO, PM ;
BARDE, SH ;
FOSTER, AC ;
LANC, RA ;
MIDDLETON, E .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (03) :316-323